Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/26/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. R. Dean Hautamaki

Wrong Dr. R. Dean Hautamaki?

Board Member

Phone: (510) ***-****  HQ Phone
WaferGen Biosystems Inc
7400 Paseo Padre Parkway
Fremont , California 94555
United States

Company Description: WaferGen Bio-systems, Inc. (WBSI) is engaged in the development, manufacture, and sale of systems for gene expression, genotyping, and stem-cell research for the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D.
  • University of Florida College of Medicine
31 Total References
Web References
Board of Directors | Wafergen
www.wafergen.com, 26 Oct 2014 [cached]
R. Dean Hautamaki, M.D.
Director
Dr. Hautamaki has served as our director since the closing of the Merger. Dr. Hautamaki is a practicing physician and since January 2005 has been the Assistant Clinical Professor of Medicine at the Florida State University College of Medicine in Tallahassee, Florida. From September 2003 to December 2005, Dr. Hautamaki was the Chairman of the Department of Medicine at Sarasota Memorial Hospital in Sarasota, Florida. From September 1997 through December 2005, he was a partner at Lung Associates of Sarasota in Sarasota, Florida. Dr. Hautamaki has authored over 12 papers and presented in several conferences.
First Wave Technologies |
www.firstwavetechnologies.com, 17 Feb 2014 [cached]
Dean Hautamaki, M.D. First Wave Technologies |
...
Dean Hautamaki, M.D. - Director
Dean Hautamaki, M.D., is a practicing Board Certified Internist/Pulmonary-Critical Care Specialist in Sarasota, Florida. He is a graduate of the University of Florida College of Medicine, completing his post-graduate training at Washington University in St. Louis, Barnes-Jewish Hospitals.
He is an Assistant Clinical Professor of Medicine with the Florida State University College of Medicine and is a past Chairman of Medicine and Director of Critical Care at Sarasota Memorial Hospital. He has presented numerous abstracts at national meetings and has published over a dozen articles in peer-reviewed journals.
He currently serves on the Board of Directors for WaferGen Bio- Systems in Fremont, California and serves on the Advisory Board of Medgenics, a development stage Israeli Biotechnology Company.
...
Dean Hautamaki, M.D. - Director
Medgenics advisors
www.medgenics.com, 30 Dec 2013 [cached]
Raymond D. Hautamaki, M.D. >>
Internet Wire MedicalHealth News
www1.internetwire.com, 23 May 2001 [cached]
AECB is a recurring , debilitating condition , and patients want to get better as quickly as possible , said Dean Hautamaki , MD , lead author of the study and Associate Director of Clinical Studies , Lung Associates of Sarasota and Director of Critical Care Services at Sarasota Memorial Hospital.Our findings are good news to both patients and physicians because they show that moxifloxacin effectively treats AECB in just five days , quicker than the approved courses of levofloxacin and other fluoroquinolones , which range from seven to ten days , he said.He added that the study is the first to directly compare moxifloxacin with levofloxacin for the treatment of AECB.
Study and Findings
The multicenter study employed a prospective , double-blind design to randomly assign adult patients confirmed with AECB to once-daily oral therapy of either moxifloxacin ( 400 mg ) for five days or levofloxacin ( 500 mg ) for seven days.The primary outcome was clinical response at the test-of-cure visit 7 to 21 days after therapy ended ; bacteriological responses were also assessed as a secondary measure.
Among patients who completed the study and were valid for efficacy analysis , the clinical cure rates of those given moxifloxacin ( 227 total ) and levofloxacin ( 234 total ) were statistically equivalent : 93 percent and 94 percent , respectively.
...
www.sec.gov, 11 June 2014 [cached]
0001435644 Hautamaki R Dean C/O WAFERGEN BIO-SYSTEMS, INC. 7400 PASEO PADRE PARKWAY FREMONT CA 94555 1 0 0 0
Other People with the name "Hautamaki":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304